Gil-Ibañez B, Glickman A, Del Pino M, Boada D, Fuste P, Diaz-Feijoo B, Pahisa J, Torne A
Unit of Gynecologic Oncology, Clinical Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Unit of Gynecologic Oncology, Clinical Institute of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Eur J Obstet Gynecol Reprod Biol. 2020 Aug;251:23-27. doi: 10.1016/j.ejogrb.2020.05.039. Epub 2020 May 19.
The aim of this study was to evaluate the oncological outcomes of vaginal fertility-sparing surgery plus laparoscopic sentinel lymph node biopsy in patients with early cervical cancer over a 15-years period.
From March 2005 to April 2018, 38 patients diagnosed with early stage cervical cancer underwent vaginal fertility-sparing surgery at the Hospital Clínic, Barcelona, Spain. Patients with FIGO stage IA1 with lymphovascular space invasion and stage IA2 underwent simple trachelectomy and patients with stage IB1 underwent radical vaginal trachelectomy. All cases underwent laparoscopic sentinel lymph node biopsy. In the first 19 cases, laparoscopic bilateral pelvic lymphadenectomy was completed immediately after sentinel lymph node biopsy. Clinical and oncological follow-up data were collected.
The median age at diagnosis was 33.5 years (range 22-44). Simple trachelectomy was performed in seven cases (18.4%) and vaginal radical trachelectomy in 31 (81.6%). Nineteen patients were exclusively treated with laparoscopic sentinel lymph node biopsy and 19 with sentinel lymph node biopsy plus laparoscopic bilateral pelvic lymphadenectomy. There were no significant differences between the two lymph node assessment groups regarding histology and tumour size. The median follow-up was 73 months (range 1-160 months). There were 4 recurrences (3 patients with IB1 and 1 with IA2). Two occurred in the sentinel lymph node biopsy group and 2 in the sentinel lymph node biopsy plus laparoscopic bilateral pelvic lymphadenectomy group. All the recurrences were diagnosed in patients with adenocarcinoma and in 3 patients without lymphovascular space invasion.
Vaginal fertility-sparing surgery combined with laparoscopic sentinel lymph node biopsy seems to be a safe oncological procedure in selected patients with early stage cervical cancer. Further studies are needed to clarify the role of sentinel lymph node biopsy in fertility- sparing surgery in cervical cancer. Adenocarcinoma histology seems to be an important risk factor for recurrence.
本研究旨在评估15年间早期宫颈癌患者行保留生育功能的阴道手术加腹腔镜前哨淋巴结活检的肿瘤学结局。
2005年3月至2018年4月,38例诊断为早期宫颈癌的患者在西班牙巴塞罗那临床医院接受了保留生育功能的阴道手术。国际妇产科联盟(FIGO)IA1期伴脉管间隙浸润及IA2期患者行单纯宫颈切除术,IB1期患者行根治性阴道宫颈切除术。所有病例均行腹腔镜前哨淋巴结活检。前19例患者在进行前哨淋巴结活检后立即完成腹腔镜双侧盆腔淋巴结清扫术。收集临床和肿瘤学随访数据。
诊断时的中位年龄为33.5岁(范围22 - 44岁)。7例(18.4%)患者行单纯宫颈切除术,31例(81.6%)行根治性阴道宫颈切除术。19例患者仅接受腹腔镜前哨淋巴结活检,19例接受前哨淋巴结活检加腹腔镜双侧盆腔淋巴结清扫术。两组淋巴结评估在组织学和肿瘤大小方面无显著差异。中位随访时间为73个月(范围1 - 1166个月)。有4例复发(3例IB1期患者和1例IA2期患者)。2例发生在前哨淋巴结活检组,2例发生在前哨淋巴结活检加腹腔镜双侧盆腔淋巴结清扫术组。所有复发均在腺癌患者中诊断出,且3例患者无脉管间隙浸润。
对于部分早期宫颈癌患者,保留生育功能的阴道手术联合腹腔镜前哨淋巴结活检似乎是一种安全的肿瘤学手术方式。需要进一步研究以阐明前哨淋巴结活检在宫颈癌保留生育功能手术中的作用。腺癌组织学似乎是复发的一个重要危险因素。